Literature DB >> 15778509

Metabolic mechanisms of tumor resistance to T cell effector function.

Candace M Cham1, Thomas F Gajewski.   

Abstract

Established tumors develop ways to elude destruction by the host immune system. Recent work has revealed that tumors can take advantage of the generation of metabolic dysregulation to inhibit immune responses. Effector T-cell functions are particularly sensitive to nutrient availability in the tumor microenvironment. In this review, we highlight experimental data supporting the importance of glucose, oxygen, tryptophan, and arginine for optimal T-cell function, and the mechanisms by which these nutrients may become depleted in the tumor microenvironment. These observations provide a conceptual framework for modulating metabolic features of the T cell-tumor interaction, toward the end of promoting more effective immune-mediated tumor destruction in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778509     DOI: 10.1385/IR:31:2:107

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  98 in total

1.  Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis.

Authors:  Lori R Kisley; Bradley S Barrett; Alison K Bauer; Lori D Dwyer-Nield; Benjamin Barthel; Amy M Meyer; David C Thompson; Alvin M Malkinson
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

2.  c-Myc is required for the glucose-mediated induction of metabolic enzyme genes.

Authors:  James J Collier; Thuy-Trang T Doan; Marc C Daniels; Jill R Schurr; Jay K Kolls; Donald K Scott
Journal:  J Biol Chem       Date:  2002-12-11       Impact factor: 5.157

Review 3.  Nitric oxide and peroxynitrite interactions with mitochondria.

Authors:  Rafael Radi; Adriana Cassina; Roberto Hodara
Journal:  Biol Chem       Date:  2002 Mar-Apr       Impact factor: 3.915

4.  Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species.

Authors:  K A Brand; U Hermfisse
Journal:  FASEB J       Date:  1997-04       Impact factor: 5.191

5.  Role of oxygen in T cell-mediated cytolysis.

Authors:  C F Nathan; J A Mercer-Smith; N M Desantis; M A Palladino
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

6.  Th1/Th2-regulated expression of arginase isoforms in murine macrophages and dendritic cells.

Authors:  M Munder; K Eichmann; J M Morán; F Centeno; G Soler; M Modolell
Journal:  J Immunol       Date:  1999-10-01       Impact factor: 5.422

Review 7.  Role of TGF-beta in immune-evasion of cancer.

Authors:  C Beck; H Schreiber; D Rowley
Journal:  Microsc Res Tech       Date:  2001-02-15       Impact factor: 2.769

8.  Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase.

Authors:  David H Munn; Madhav D Sharma; Jeffrey R Lee; Kanchan G Jhaver; Theodore S Johnson; Derin B Keskin; Brendan Marshall; Phillip Chandler; Scott J Antonia; Russell Burgess; Craig L Slingluff; Andrew L Mellor
Journal:  Science       Date:  2002-09-13       Impact factor: 47.728

9.  Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase.

Authors:  Catherine Uyttenhove; Luc Pilotte; Ivan Théate; Vincent Stroobant; Didier Colau; Nicolas Parmentier; Thierry Boon; Benoît J Van den Eynde
Journal:  Nat Med       Date:  2003-09-21       Impact factor: 53.440

10.  Inhibition of indoleamine 2,3-dioxygenase activity in IFN-gamma stimulated astroglioma cells decreases intracellular NAD levels.

Authors:  Ross Grant; Vimal Kapoor
Journal:  Biochem Pharmacol       Date:  2003-09-15       Impact factor: 5.858

View more
  8 in total

1.  mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function.

Authors:  Raymond P Donnelly; Róisín M Loftus; Sinéad E Keating; Kevin T Liou; Christine A Biron; Clair M Gardiner; David K Finlay
Journal:  J Immunol       Date:  2014-09-26       Impact factor: 5.422

Review 2.  Filling the Tank: Keeping Antitumor T Cells Metabolically Fit for the Long Haul.

Authors:  Greg M Delgoffe
Journal:  Cancer Immunol Res       Date:  2016-12       Impact factor: 11.151

Review 3.  Combination of physical activity, nutrition, or other metabolic factors and vaccine response.

Authors:  Kenneth W Hance; Connie J Rogers; Stephen D Hursting; John W Greiner
Journal:  Front Biosci       Date:  2007-09-01

4.  An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression.

Authors:  Asis Palazon; Petros A Tyrakis; David Macias; Pedro Veliça; Helene Rundqvist; Susan Fitzpatrick; Nikola Vojnovic; Anthony T Phan; Niklas Loman; Ingrid Hedenfalk; Thomas Hatschek; John Lövrot; Theodoros Foukakis; Ananda W Goldrath; Jonas Bergh; Randall S Johnson
Journal:  Cancer Cell       Date:  2017-11-13       Impact factor: 31.743

5.  [The systemic evaluation and clinical significance of immunological function for advanced lung cancer patients].

Authors:  Tuya Wulan; Shiyong Wang; Weili Du; Hui Zhang; Yuan Zhang; Xue Zeng; Sa Liu; Yanping Liu; Lu Zhang; Zhe Zhang; Ying He; Jialing Wang; Xiuyan Wu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-04

6.  IL-36β Promotes CD8+ T Cell Activation and Antitumor Immune Responses by Activating mTORC1.

Authors:  Xin Zhao; Xiaojuan Chen; Xinghua Shen; Peijun Tang; Chen Chen; Qitai Zhu; Muyao Li; Rui Xia; Xi Yang; Chao Feng; Xinguo Zhu; Yibei Zhu; Zhongwen Sun; Xueguang Zhang; Binfeng Lu; Xuefeng Wang
Journal:  Front Immunol       Date:  2019-08-07       Impact factor: 7.561

Review 7.  Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials.

Authors:  Zhenyi Niu; Runsen Jin; Yan Zhang; Hecheng Li
Journal:  Signal Transduct Target Ther       Date:  2022-10-05

Review 8.  Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes.

Authors:  Matteo Bellone; Arianna Calcinotto
Journal:  Front Oncol       Date:  2013-09-11       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.